• Spark Biomedical has been awarded a $318,875 SBIR grant from the National Institute on Drug Abuse (NIDA) to develop an AI algorithm for detecting opioid withdrawal symptoms and cravings.
• The AI algorithm will analyze data from wearable devices that measure digital and physical biomarkers, along with clinical assessments, to proactively identify withdrawal symptoms.
• The second phase of the project will apply the AI algorithm to trigger closed-loop neurostimulation using Spark Biomedical’s Sparrow Ascent device for timely intervention.
• The collaboration with Battelle Memorial Institute and Hazelden Betty Ford Foundation aims to improve treatment effectiveness, patient compliance, and reduce relapse rates in opioid use disorder (OUD) recovery.